Advertisement

Reactions Weekly

, Volume 1774, Issue 1, pp 187–187 | Cite as

Infliximab/ustekinumab

Sporadic Creutzfeldt-Jakob disease: case report
Case report

Reference

  1. Timothy Z, et al. Development of Creutzfeldt-Jakob disease during infliximab and ustekinumab therapy for refractory Crohn's colitis. American Journal of Gastroenterology 114 (Suppl. 1): S22-S23 abstr. P084, Jul 2019. Available from: URL: http://doi.org/10.14309/01.ajg.0000578408.31427.8a [abstract] - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations